02.27.26 -- Site Management And Oversight Become Must-Haves For Successful Sites

Experts predict 2026 trends: more pragmatic trial design, expanded use of data and AI for patient matching, and registration and reporting of results for all human trials.

Regulators are sharpening their focus on ocular safety in GLP-1 receptor agonist trials following emerging evidence linking semaglutide to non-arteritic anterior ischemic optic neuropathy (NAION).

This dynamic, system-agnostic approach to modernizing clinical trial monitoring supports targeted oversight, as well as sampling at the subject, visit, and form levels.

Oversight in 2026 requires adaptability as AI, consent standards, and regulatory uncertainty challenge sponsors and IRBs to balance ethics with innovation through proactive planning and collaboration.

Explore how technology-driven, patient-centered innovation is transforming clinical trials to reduce risk, improve efficiency, and deliver smarter development outcomes.

AI can enhance IRT with predictive modeling and automation, but true success relies on high-quality data, compliance, and user trust. Learn practical strategies to boost efficiency.

Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.

Gain instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs on a flexible learning platform.